<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">diaendo</journal-id><journal-title-group><journal-title xml:lang="ru">Сахарный диабет</journal-title><trans-title-group xml:lang="en"><trans-title>Diabetes mellitus</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0351</issn><issn pub-type="epub">2072-0378</issn><publisher><publisher-name>Endocrinology research centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/DM12780</article-id><article-id custom-type="elpub" pub-id-type="custom">diaendo-12780</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original Studies</subject></subj-group></article-categories><title-group><article-title>Состояние функции эндотелия у мужчин с гипогонадизмом</article-title><trans-title-group xml:lang="en"><trans-title>Endothelial function status in hypogonadal men</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0284-295X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хрипун</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Khripun</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хрипун Ирина Алексеевна - доктор медицинских наук, доцент; eLibrary SPIN: 8630-4828.</p><p>344022, Ростов-на-Дону, пер. Нахичеванский, д. 29</p></bio><bio xml:lang="en"><p>Irina I. Khripun - MD, PhD, assistant professor; eLibrary SPIN: 8630-4828.</p><p>29, Nakhichevanski lane, 344022 Rostov on Don</p></bio><email xlink:type="simple">khripun.irina@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7884-2433</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воробьев</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Vorobyev</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Воробьев Сергей Владиславович - доктор медицинских наук, профессор; eLibrary SPIN: 9773-6100</p><p>344022, Ростов-на-Дону, пер. Нахичеванский, д. 29</p></bio><bio xml:lang="en"><p>Sergey V. Vorobyev, MD, PhD, Professor; eLibrary SPIN: 9773-6100</p><p>29, Nakhichevanski lane, 344022 Rostov on Don</p></bio><email xlink:type="simple">endocrinrostov@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ростовский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Rostov State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>04</day><month>01</month><year>2022</year></pub-date><volume>24</volume><issue>5</issue><fpage>440</fpage><lpage>447</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Хрипун И.А., Воробьев С.В., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Хрипун И.А., Воробьев С.В.</copyright-holder><copyright-holder xml:lang="en">Khripun I.A., Vorobyev S.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.dia-endojournals.ru/jour/article/view/12780">https://www.dia-endojournals.ru/jour/article/view/12780</self-uri><abstract><sec><title>Обоснование</title><p>Обоснование. Сахарный диабет 2 типа (СД2) и гипогонадизм являются взаимоотягощающими состояниями, ассоциированными с развитием и прогрессией кардиоваскулярных заболеваний. Состояние функции эндотелия у мужчин с СД2 на фоне гипогонадизма мало изучено.</p></sec><sec><title>Цель</title><p>Цель. Оценить влияние гипогонадизма на функцию эндотелия у мужчин с СД2.</p></sec><sec><title>Методы</title><p>Методы. Больным проводили общеклинические исследования, изучение состояния углеводного и липидного обменов, содержания половых гормонов (общего тестостерона (Т), глобулина, связывающего половые гормоны, свободного Т, лютеинизирующего гормона) и маркеров функции эндотелия (оксида азота (NO), эндотелиальной синтазы оксида азота 3 типа (eNOS3), эндотелина, молекул адгезии ICAM-1, VCAM-1, p- и е-селектинов, кадгерина), выполняли ультразвуковые исследования эндотелий-зависимой вазодилатации (ЭЗВД) плечевой артерии (ПА) и сонных артерий с оценкой толщины комплекса интима-медиа (КИМ).</p></sec><sec><title>Результаты</title><p>Результаты. В исследование вошли 276 мужчин с СД2 (возраст 54,0 [49; 60] года), которые были разделены на 2 группы: 1 — 124 больных, имеющих гипогонадизм; 2 — 152 эугонадных пациента. Нарушение сосудодвигательной функции эндотелия было выявлено у 32,4% больных 2-й группы и у 55,3% 1-й группы (χ2=6,1; р=0,01), что было ассоциировано со снижением ЭЗВД на 29,8% (р&lt;0,001) и увеличением времени развития максимальной вазодилатации ПА на 30 с у больных гипогонадизмом (р&lt;0,001). Толщина КИМ сонных артерий была больше на 10% в 1-й группе по сравнению со 2-й (р=0,03). Содержание NO в 1-й группе было снижено в 1,6 раза (р=0,001), eNOS3 — в 1,5 раза (р=0,038) по сравнению со 2-й группой. Концентрации молекул адгезии были выше в 1-й группе по сравнению со 2-й: VCAM-1 — на 32,5% (р&lt;0,001), ICAM-1 — на 43,5% (р&lt;0,001), р-селектина — на 19,3% (р=0,004), кадгерина — в 6 раз (р&lt;0,001).</p></sec><sec><title>Заключение</title><p>Заключение. Гипогонадизм у мужчин с СД2 ассоциирован с развитием дисфункции эндотелия, что проявляется в ослаблении ЭЗВД и замедлении ее развития, а также нарушении секреторной активности эндотелия — снижении синтеза NO и активации экспрессии молекул адгезии, что может являться универсальным патогенетическим механизмом развития сердечно-сосудистых заболеваний при сочетании дефицита Т и СД2.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background: Type 2 diabetes mellitus (T2DM) and hypogonadism are mutually aggravating diseases associated with the development and progression of cardiovascular pathology. The status of endothelial function in men with T2DM and hypogonadism hasn’t been studied.</p></sec><sec><title>Aims</title><p>Aims: To assess the effect of hypogonadism on endothelial function in men with T2DM.</p></sec><sec><title>Materials and methods</title><p>Materials and methods: Patients underwent clinical studies, assessment of carbohydrate and lipid metabolism, the content of sex hormones (total testosterone (T), sex hormones binding globulin, free T, luteinizing hormone) and markers of endothelial function (nitric oxide (NO), endothelial nitric oxide synthase type 3 (eNOS3), endothelin, adhesion molecules ICAM-1, VCAM-1, p- and e-selectins, cadherin), ultrasound examinations of endothelium-dependent vasodilation (EDVD) of the brachial artery (BA) and carotid arteries with an assessment of the thickness of intima-media complex (TIM) were performed.</p></sec><sec><title>Results</title><p>Results: The study included 276 men with T2DM (age 54.0[49;60] years), who were divided into 2 groups: 1–124 patients with hypogonadism; 2–152 eugonadal patients. Reduction of the endothelial vasomotor function was detected in 32.4% of patients in the 2st group and in 55.3% of the 1nd group (χ2=6.1; p=0.01), which was associated with a decrease in EDVD by 29.8 % (p&lt;0.001) and an increase in the time of development of maximal BA vasodilation by 30 seconds in patients with hypogonadism (p&lt;0.001). The TIM of the carotid arteries was 10% more in group 1 compared with group 2 (p=0.03). The ­level of NO in the 1st group was reduced by 1.6 times (p=0.001), eNOS3–by 1.5 times (p=0.038) compared with the 2nd group. The concentrations of adhesion molecules were higher in group 1 compared to group 2: VCAM-1 by 32.5% (p&lt;0.001), ICAM-1 by 43.5% (p&lt;0.001), p-selectin–by 19.3% (p=0.004), cadherin–6 times (p&lt;0.001).</p></sec><sec><title>Conclusion</title><p>Conclusion: Hypogonadism in men with T2DM is associated with the development of endothelial dysfunction, which manifests in a weakening of the EDVD and a slowdown in its development, as well as disturbances of the secretory activity of endothelium–a decrease in NO synthesis and activation of the adhesion molecules expression, which can be regarded as an universal pathogenetic mechanism of the development of cardiovascular diseases in combination of T deficiency and T2DM.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>гипогонадизм</kwd><kwd>тестостерон</kwd><kwd>сахарный диабет</kwd><kwd>сердечно-сосудистые заболевания</kwd><kwd>эндотелий</kwd><kwd>эндотелиальная дисфункция</kwd><kwd>эндотелий-зависимая вазодилатация</kwd><kwd>толщина комплекса интима-медиа</kwd><kwd>оксид азота</kwd><kwd>молекулы адгезии</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hypogonadism</kwd><kwd>testosterone</kwd><kwd>diabetes mellitus</kwd><kwd>cardiovascular diseases</kwd><kwd>endothelium</kwd><kwd>endothelial dysfunction</kwd><kwd>endothelium dependent vasodilation</kwd><kwd>the thickness of the intima-media complex</kwd><kwd>nitric oxide</kwd><kwd>adhesion molecules</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена при поддержке Российского научного фонда, грант № 14-25-00052. Авторы выражают признательность всем членам научного коллектива, осуществлявшим работу по реализации гранта Российского научного фонда № 14-25-00052</funding-statement><funding-statement xml:lang="en">Russian Science Foundation, grant № 14-25-00052</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">IDF diabetes atlas, 9th edition 2019. International Diabetes Federation. — IDF, 2020. Available from: https://www.diabetesatlas.org/en/ (12.06.2020).</mixed-citation><mixed-citation xml:lang="en">IDF diabetes atlas, 9th edition 2019. International Diabetes Federation. — IDF, 2020. Available from: https://www.diabetesatlas.org/en/ (12.06.2020).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Аметов А.С. Сахарный диабет 2 типа. Проблемы и решения. 3-е изд., перераб. и доп. — М.: ГЭОТАР-Медиа; 2015. — Т. 1. — 352 с.</mixed-citation><mixed-citation xml:lang="en">Ametov A.S. Saharnyj diabet 2 tipa. Problemy i reshenija. 3-e izd., pererab. i dop. M.: GЕOTAR-Media; 2015. 352 р. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Takeda Y, Matoba K, Sekiguchi K, et al. Endothelial Dysfunction in Diabetes. Biomedicines. 2020;8(7):182. doi: https://doi.org/10.3390/biomedicines8070182.</mixed-citation><mixed-citation xml:lang="en">Takeda Y, Matoba K, Sekiguchi K, et al. Endothelial Dysfunction in Diabetes. Biomedicines. 2020;8(7):182. doi: https://doi.org/10.3390/biomedicines8070182.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Godo S, Shimokawa H. Endothelial Functions. Arterioscler. Thromb. Vasc. Biol. 2017;37(9):e108-e114. doi: https://doi.org/10.1161/ATVBAHA.117.309813</mixed-citation><mixed-citation xml:lang="en">Godo S, Shimokawa H. Endothelial Functions. Arterioscler. Thromb. Vasc. Biol. 2017;37(9):e108-e114. doi: https://doi.org/10.1161/ATVBAHA.117.309813</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Хрипун И.А., Воробьев С.В., Моргунов М.Н., Коган М.И. Функция эндотелия у мужчин с сахарным диабетом 2 типа, не имеющих клинических признаков сердечно-сосудистых заболеваний // Сахарный диабет. — 2016. — Т. 19. — №5. — С. 383-387. doi: https://doi.org/10.14341/DM8017</mixed-citation><mixed-citation xml:lang="en">Khripun IA, Vorobyev SV, Morgunov MN, Kogan MI. Endothelial function in men with type 2 diabetes without clinical signs of cardiovascular disease. Diabetes mellitus. 2016;19(5):383-387. (In Russ.). doi: https://doi.org/10.14341/DM8017</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Triggle CR, Ding H, Marei I, Anderson TJ, Hollenberg MD. Why the endothelium? The endothelium as a target to reduce diabetes-associated vascular disease. Can J Physiol Pharmacol. 2020;98(7):415-430. doi: https://doi.org/10.1139/cjpp-2019-0677</mixed-citation><mixed-citation xml:lang="en">Triggle CR, Ding H, Marei I, Anderson TJ, Hollenberg MD. Why the endothelium? The endothelium as a target to reduce diabetes-associated vascular disease. Can J Physiol Pharmacol. 2020;98(7):415-430. doi: https://doi.org/10.1139/cjpp-2019-0677</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang J, Li X, Cai Z, et al. Association between testosterone with type 2 diabetes in adult males, a meta-analysis and trial sequential analysis. Aging Male. 2020;23(5):607-618. doi: https://doi.org/10.1080/13685538.2018.1557139</mixed-citation><mixed-citation xml:lang="en">Zhang J, Li X, Cai Z, et al. Association between testosterone with type 2 diabetes in adult males, a meta-analysis and trial sequential analysis. Aging Male. 2020;23(5):607-618. doi: https://doi.org/10.1080/13685538.2018.1557139</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Rastrelli G, Filippi S, Sforza A, et al. Metabolic Syndrome in Male Hypogonadism. In: Frontiers of Hormone Research. 2018:131-155. doi: https://doi.org/10.1159/000485999</mixed-citation><mixed-citation xml:lang="en">Rastrelli G, Filippi S, Sforza A, et al. Metabolic Syndrome in Male Hypogonadism. In: Frontiers of Hormone Research. 2018:131-155. doi: https://doi.org/10.1159/000485999</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Jones TH, Kelly DM. Randomized controlled trials-mechanistic studies of testosterone and the cardiovascular system. Asian J Androl. 2018. doi: https://doi.org/10.4103/aja.aja-6-18</mixed-citation><mixed-citation xml:lang="en">Jones TH, Kelly DM. Randomized controlled trials-mechanistic studies of testosterone and the cardiovascular system. Asian J Androl. 2018. doi: https://doi.org/10.4103/aja.aja-6-18</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Мельниченко Г.А., Шестакова М.В., Роживанов Р.В. Распространенность синдрома гипогонадизма у мужчин с сахарным диабетом типа 2 в условиях рутинной клинической практики // Сахарный диабет. — 2019. — Т. 22. — №2. — С. 127-130. doi: https://doi.org/10.14341/DM9944</mixed-citation><mixed-citation xml:lang="en">Melnichenko GA, Shestakova MV, Rozhivanov RV. The prevalence of hypogonadism in men with diabetes mellitus (DM) type 2 in clinical practice. Diabetes Mellitus. 2019;22(2):127-130. (In Russ.). doi: https://doi.org/10.14341/DM9944</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Blaya R, Blaya P, Rhoden L, et al. Low Testosterone Levels and Metabolic Syndrome in Aging Male. Curr Pharm Des. 2017;23(30):4470-4474. doi: https://doi.org/10.2174/1381612823666170503150955</mixed-citation><mixed-citation xml:lang="en">Blaya R, Blaya P, Rhoden L, et al. Low Testosterone Levels and Metabolic Syndrome in Aging Male. Curr Pharm Des. 2017;23(30):4470-4474. doi: https://doi.org/10.2174/1381612823666170503150955</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Lucas-Herald AK, Alves-Lopes R, Montezano AC, et al. Genomic and non-genomic effects of androgens in the cardiovascular system: clinical implications. Clin. Sci. (Lond). 2017;131(13):1405-1418. doi: https://doi.org/10.1042/CS20170090</mixed-citation><mixed-citation xml:lang="en">Lucas-Herald AK, Alves-Lopes R, Montezano AC, et al. Genomic and non-genomic effects of androgens in the cardiovascular system: clinical implications. Clin. Sci. (Lond). 2017;131(13):1405-1418. doi: https://doi.org/10.1042/CS20170090</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Chistiakov DA, Myasoedova VA, Melnichenko AA, et al. Role of androgens in cardiovascular pathology. Vasc. Health Risk Manag. 2018;14:283-290.</mixed-citation><mixed-citation xml:lang="en">Chistiakov DA, Myasoedova VA, Melnichenko AA, et al. Role of androgens in cardiovascular pathology. Vasc. Health Risk Manag. 2018;14:283-290.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Torres-Estay V, Carreño DV, Fuenzalida P, et al. Androgens modulate male-derived endothelial cell homeostasis using androgen receptor-dependent and receptor-independent mechanisms. Angiogenesis. 2017;20(1):25-38. doi: https://doi.org/10.1007/s10456-016-9525-6</mixed-citation><mixed-citation xml:lang="en">Torres-Estay V, Carreño DV, Fuenzalida P, et al. Androgens modulate male-derived endothelial cell homeostasis using androgen receptor-dependent and receptor-independent mechanisms. Angiogenesis. 2017;20(1):25-38. doi: https://doi.org/10.1007/s10456-016-9525-6</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Хрипун И.А., Воробьев С.В., Коган М.И. Взаимосвязь полиморфизма гена рецептора андрогенов и функции эндотелия у мужчин с сахарным диабетом 2 типа // Сахарный диабет. — 2015. — № 4. — С. 28-33. doi: https://doi.org/10.14341/DM7622</mixed-citation><mixed-citation xml:lang="en">Khripun IA, Vorobiev SV, Kogan MI. Association of the polymorphism in the androgen receptor gene and endothelial function in men with type 2 diabetes. Diabetes mellitus. 2015;4:28-33. (In Russ.). doi: https://doi.org/10.14341/DM7622</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Nambi V, Chambless L, He M, et al. Common carotid artery intima-media thickness is as good as carotid intima-media thickness of all carotid artery segments in improving prediction of coronary heart disease risk in the Atherosclerosis Risk in Communities (ARIC) study. Eur. Heart J. 2012;33(2):183-190. doi: https://doi.org/10.1093/eurheartj/ehr192</mixed-citation><mixed-citation xml:lang="en">Nambi V, Chambless L, He M, et al. Common carotid artery intima-media thickness is as good as carotid intima-media thickness of all carotid artery segments in improving prediction of coronary heart disease risk in the Atherosclerosis Risk in Communities (ARIC) study. Eur. Heart J. 2012;33(2):183-190. doi: https://doi.org/10.1093/eurheartj/ehr192</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Хрипун И.А., Моргунов М.Н., Воробьев С.В., и др. Эндотелиальная дисфункция и сахарный диабет 2 типа: новые маркеры ранней диагностики // Кардиоваскулярная терапия и профилактика. — 2016. — Т. 15. — № 5. — С. 59-63. doi: https://doi.org/10.15829/1728-8800-2016-5-59-63</mixed-citation><mixed-citation xml:lang="en">Khripun IA, Morgunov MN, Vorobyov SV, et al. Endothelial dysfuncton and 2 type diabetes: novel markers for earlier diagnostics. Cardiovascular Therapy and Prevention. 2016;15(5):59-63. (In Russ.). doi: https://doi.org/10.15829/1728-8800-2016-5-59-63</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Farah C, Michel LYM, Balligand JL. Nitric oxide signalling in cardiovascular health and disease. Nat Rev Cardiol. 2018;15(5):292-316. doi: https://doi.org/10.1038/nrcardio.2017.224</mixed-citation><mixed-citation xml:lang="en">Farah C, Michel LYM, Balligand JL. Nitric oxide signalling in cardiovascular health and disease. Nat Rev Cardiol. 2018;15(5):292-316. doi: https://doi.org/10.1038/nrcardio.2017.224</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Hotta Y, Kataoka T, Kimura K. Testosterone Deficiency and Endothelial Dysfunction: Nitric Oxide, Asymmetric Dimethylarginine, and Endothelial Progenitor Cells. Sex Med Rev. 2019;7(4):661-668. doi: https://doi.org/10.1016/j.sxmr.2019.02.005</mixed-citation><mixed-citation xml:lang="en">Hotta Y, Kataoka T, Kimura K. Testosterone Deficiency and Endothelial Dysfunction: Nitric Oxide, Asymmetric Dimethylarginine, and Endothelial Progenitor Cells. Sex Med Rev. 2019;7(4):661-668. doi: https://doi.org/10.1016/j.sxmr.2019.02.005</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Степанова Т.В., Иванов А.Н., Терешкина Н.Е., и др. Маркеры эндотелиальной дисфункции: патогенетическая роль и диагностическое значение (обзор литературы) // Клиническая и лабораторная диагностика. — 2019. — Т. 64. — №1. — С. 34-41.</mixed-citation><mixed-citation xml:lang="en">Stepanova TV, Ivanov AN, Tereshkina NE, et al. Markery jendotelial’noj disfunkcii: patogeneticheskaja rol’ i diagnosticheskoe znachenie (obzor literatury) / Klinicheskaja i laboratornaja diagnostika. 2019;64(1):34-41 (In Russ.).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
